Whitefort Capital Management, LP

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Whitefort Capital Management, LP reported 13 stock positions worth $153.2 million. Its top holding was Global Ship Lease Class A (GSL) at 26.2% of the portfolio, followed by Arbutus Biopharma (ABUS, 21.7%) and Roivant Sciences (ROIV, 16.4%). Compared with Q4 2023, it sold out of 2, added to 6 and reduced 2. The biggest buy was Roivant Sciences (ROIV, shares +50%) and the biggest sale Nextnav (NN, shares −51%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001884931
Portfolio Value
$153.2M (Q1 2024)
SEC Filing
0001013594-24-000485 ↗ filed May 15, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q1 2024: $153.2M $153.2M Q1 2024 Q2 2024: $143.4M Q2 2024 Q3 2024: $201.5M Q3 2024 Q4 2024: $191.5M Q4 2024 Q1 2025: $185.2M Q1 2025 Q2 2025: $239.0M Q2 2025 Q3 2025: $287.4M Q3 2025 Q4 2025: $317.7M Q4 2025 Q1 2026: $316.6M Q1 2026 Q2 2026: $391.6M Q2 2026

Holdings 13 stocks · $153.2M
GSL Global Ship Lease Inc. Class A 26.19% 1,977,224 $40.1M Add +4.2%
ABUS Arbutus Biopharma Corp. 21.65% 12,862,152 $33.2M Reduce -2.5%
ROIV Roivant Sciences Ltd. 16.45% 2,391,000 $25.2M Add +50.3%
LSXMK Liberty Media Corp.-Liber-New 8.85% 456,285 $13.6M No change
GNW Genworth Financial Inc. 8.38% 1,996,960 $12.8M Add +31.6%
NN Nextnav Inc. 5.53% 1,286,847 $8.5M Reduce -50.7%
LLYVK Liberty Media Corp.-Liberty-C 3.26% 114,071 $5.0M No change
LQDA Liquidia Corp. 3.25% 337,607 $5.0M Add +45.8%
MHLD Maiden Holdings Ltd. 3.01% 2,048,163 $4.6M Add +4.2%
OMEX Odyssey Marine Exploration 1.36% 548,909 $2.1M No change
PBI Pitney Bowes Inc. 1.06% 373,500 $1.6M No change
VATE Innovate Corp. 0.91% 1,989,117 $1.4M Add +82.6%
TRINITY BIOTECH INVT LTD 0.11% 81,902 $167K No change
Other holdings (6): bonds, preferreds, convertibles and warrants · $10.9M (not counted above)
SecurityClassShares / PrincipalValueChange
SABRE GLBL INC (SABHLD 4 04/15/25) NOTE 4.000% 4/1 · principal 5,000,000$4.7MNo change
ESPERION THERAPEUTICS (ESPR 4 11/15/25) NOTE 4.000%11/1 · principal 4,000,000$3.3MReduce -18.4%
INNOVATE CORP (VATE 7.5 08/01/26 *) NOTE 7.500% 8/0 · principal 5,658,000$1.9MNo change
NNAVW Nextnav Inc. *W EXP 99/99/999 482,951$1.0MNo change
AEAEW Altenergy Acquisition -CW23 *W EXP 10/29/202 186,315$9KNo change
LANWF Lanvin Group Holdings Ltd.-27 *W EXP 01/14/202 100,000$5KNo change

Total filed on the 13F, all lines: $164.2M.

Portfolio Sells Q4 2023 → Q1 2024
NN Nextnav Inc. Reduce -50.7% 5.53% −2.42
CEE Central and Eastern Europe F Sold out 0.00% −2.03
ESPR Esperion Therapeutics Inc. Sold out 0.00% −1.81
ABUS Arbutus Biopharma Corp. Reduce -2.5% 21.65% −0.91

Portfolio Buys Q4 2023 → Q1 2024
ROIV Roivant Sciences Ltd. Add +50.3% 16.45% +4.23
GNW Genworth Financial Inc. Add +31.6% 8.38% +1.45
LQDA Liquidia Corp. Add +45.8% 3.25% +1.34
GSL Global Ship Lease Inc. Class A Add +4.2% 26.19% +0.48
VATE Innovate Corp. Add +82.6% 0.91% −0.01
MHLD Maiden Holdings Ltd. Add +4.2% 3.01% −0.07

Notes & Other Activity Q4 2023 → Q1 2024
ESPERION THERAPEUTICS (ESPR 4 11/15/25) NOTE 4.000%11/1 · principal Reduce -18.4% 4,000,000 $3.3M

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 18$391.6MABUS, ROIV, JOYY, BALY, GNW
Q1 2026 17$316.6MABUS, ROIV, JOYY, SOC, GNW
Q4 2025 15$317.7MABUS, ROIV, BALY, OABI, JOYY
Q3 2025 14$287.4MABUS, ROIV, GNW, JOYY, OABI
Q2 2025Amended 14$239.0MJOYY, ROIV, ABUS, GNW, OABI
Q1 2025 11$185.2MABUS, ROIV, JOYY, GNW, LQDA
Q4 2024 13$191.5MABUS, ROIV, LQDA, GNW, CDZI
Q3 2024 13$201.5MABUS, EDR, ROIV, JOYY, GNW
Q2 2024 16$143.4MABUS, ROIV, NN, GNW, GSL
Q1 2024 13$153.2MGSL, ABUS, ROIV, LSXMK, GNW